VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 397 filers reported holding VANECK VECTORS ETF TR in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,038,604 | -6.9% | 224,400 | +4.1% | 0.07% | +24.6% |
| Q2 2023 | $6,488,765 | -20.0% | 215,502 | -14.0% | 0.06% | -27.8% |
| Q1 2023 | $8,106,845 | +12.5% | 250,598 | -0.4% | 0.08% | +5.3% |
| Q4 2022 | $7,207,847 | -99.9% | 251,495 | -0.7% | 0.08% | +11.9% |
| Q3 2022 | $6,111,116,000 | +86816.7% | 253,363 | -1.3% | 0.07% | -4.3% |
| Q2 2022 | $7,031,000 | -45.9% | 256,811 | -24.3% | 0.07% | -30.0% |
| Q1 2022 | $13,007,000 | -45.5% | 339,171 | -54.5% | 0.10% | +13.6% |
| Q4 2021 | $23,882,000 | +134.8% | 745,586 | +116.1% | 0.09% | -17.0% |
| Q3 2021 | $10,170,000 | -13.2% | 345,096 | +0.1% | 0.11% | -19.1% |
| Q2 2021 | $11,711,000 | +8.4% | 344,642 | +3.7% | 0.13% | -5.1% |
| Q1 2021 | $10,800,000 | -3.1% | 332,316 | +7.4% | 0.14% | -9.2% |
| Q4 2020 | $11,146,000 | +1.7% | 309,432 | +10.6% | 0.15% | -8.4% |
| Q3 2020 | $10,957,000 | +7.6% | 279,808 | +0.8% | 0.17% | -2.4% |
| Q2 2020 | $10,183,000 | +57.0% | 277,608 | -1.4% | 0.17% | +27.8% |
| Q1 2020 | $6,484,000 | -28.1% | 281,419 | -8.6% | 0.13% | -14.7% |
| Q4 2019 | $9,012,000 | +36.5% | 307,800 | +24.6% | 0.16% | +24.8% |
| Q3 2019 | $6,600,000 | +6.3% | 247,087 | +1.7% | 0.12% | +9.6% |
| Q2 2019 | $6,207,000 | +134.6% | 242,840 | +105.8% | 0.11% | +123.5% |
| Q1 2019 | $2,646,000 | +195.3% | 118,000 | +177.6% | 0.05% | +183.3% |
| Q4 2018 | $896,000 | +222.3% | 42,500 | +183.3% | 0.02% | +260.0% |
| Q3 2018 | $278,000 | -17.0% | 15,000 | 0.0% | 0.01% | -28.6% |
| Q2 2018 | $335,000 | -7.7% | 15,000 | -9.1% | 0.01% | -12.5% |
| Q1 2018 | $363,000 | -70.5% | 16,500 | -68.9% | 0.01% | -68.0% |
| Q4 2017 | $1,231,000 | +11.7% | 52,971 | +10.4% | 0.02% | 0.0% |
| Q3 2017 | $1,102,000 | -7.6% | 47,997 | -11.1% | 0.02% | -10.7% |
| Q2 2017 | $1,192,000 | +9.0% | 53,997 | +12.6% | 0.03% | +3.7% |
| Q1 2017 | $1,094,000 | -8.2% | 47,971 | -15.8% | 0.03% | -12.9% |
| Q4 2016 | $1,192,000 | +97.7% | 56,971 | +149.9% | 0.03% | +93.8% |
| Q3 2016 | $603,000 | -37.4% | 22,800 | -34.5% | 0.02% | -38.5% |
| Q2 2016 | $964,000 | – | 34,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |